These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

575 related items for PubMed ID: 23040598

  • 1. Prognostic usefulness of the change in N-terminal pro B-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥ 70 years.
    Eggers KM, Venge P, Lind L.
    Am J Cardiol; 2013 Jan 01; 111(1):131-6. PubMed ID: 23040598
    [Abstract] [Full Text] [Related]

  • 2. Glomerular filtration rate and N-terminal pro-brain natriuretic peptide as predictors of cardiovascular mortality in vascular patients.
    Shadman R, Allison MA, Criqui MH.
    J Am Coll Cardiol; 2007 Jun 05; 49(22):2172-81. PubMed ID: 17543637
    [Abstract] [Full Text] [Related]

  • 3. Usefulness and predictive value of circulating NT-proBNP levels to stratify patients for referral and priority treatment in a specialized outpatient heart failure center.
    Amir O, Paz H, Ammar R, Yaniv N, Schliamser JE, Lewis BS.
    Isr Med Assoc J; 2008 Feb 05; 10(2):109-12. PubMed ID: 18432021
    [Abstract] [Full Text] [Related]

  • 4. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 5. Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure.
    Michtalik HJ, Yeh HC, Campbell CY, Haq N, Park H, Clarke W, Brotman DJ.
    Am J Cardiol; 2011 Apr 15; 107(8):1191-5. PubMed ID: 21296322
    [Abstract] [Full Text] [Related]

  • 6. Risk stratification in stable coronary artery disease: superiority of N-terminal pro B-type natriuretic peptide over high-sensitivity C-reactive protein, gamma-glutamyl transferase, and traditional risk factors.
    Bode E, Wuppinger T, Bode T, Alber H, Ulmer H, Pachinger O, Mair J.
    Coron Artery Dis; 2012 Mar 15; 23(2):91-7. PubMed ID: 22157356
    [Abstract] [Full Text] [Related]

  • 7. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery.
    Feringa HH, Schouten O, Dunkelgrun M, Bax JJ, Boersma E, Elhendy A, de Jonge R, Karagiannis SE, Vidakovic R, Poldermans D.
    Heart; 2007 Feb 15; 93(2):226-31. PubMed ID: 16914484
    [Abstract] [Full Text] [Related]

  • 8. N-terminal pro-brain natriuretic peptide and angiotensin-converting enzyme-2 levels and their association with postoperative cardiac complications after emergency orthopedic surgery.
    Chong CP, Lim WK, Velkoska E, van Gaal WJ, Ryan JE, Savige J, Burrell LM.
    Am J Cardiol; 2012 May 01; 109(9):1365-73. PubMed ID: 22381157
    [Abstract] [Full Text] [Related]

  • 9. Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro-B-type natriuretic peptide: a Clopidogrel for the Reduction of Events During Observation (CREDO) substudy.
    Tang WH, Steinhubl SR, Van Lente F, Brennan D, McErlean E, Maroo A, Francis GS, Topol EJ.
    Am Heart J; 2007 Jan 01; 153(1):36-41. PubMed ID: 17174634
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D, van Kuijk JP, Flu WJ, Hoeks SE, Chonchol M, Verhagen HJ, Bax JJ, Poldermans D.
    Am J Cardiol; 2011 Feb 15; 107(4):609-14. PubMed ID: 21185000
    [Abstract] [Full Text] [Related]

  • 12. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in a Japanese community: the Hisayama study.
    Doi Y, Ninomiya T, Hata J, Hirakawa Y, Mukai N, Ikeda F, Fukuhara M, Iwase M, Kiyohara Y.
    Arterioscler Thromb Vasc Biol; 2011 Dec 15; 31(12):2997-3003. PubMed ID: 21921261
    [Abstract] [Full Text] [Related]

  • 13. Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.
    Vaes B, de Ruijter W, Degryse J, Westendorp RG, Gussekloo J.
    J Am Geriatr Soc; 2009 May 15; 57(5):823-9. PubMed ID: 19470010
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
    Jonsson G, Abdelnoor M, Landaas S, Muller C, Kjeldsen SE, Os I, Westheim A.
    Cardiology; 2006 May 15; 106(2):102-8. PubMed ID: 16636540
    [Abstract] [Full Text] [Related]

  • 15. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov 15; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 16. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O, Hoeks SE, Goei D, Bax JJ, Verhagen HJ, Poldermans D.
    J Vasc Surg; 2009 Feb 15; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [Abstract] [Full Text] [Related]

  • 17. N-terminal pro B-type natriuretic peptide in the early evaluation of suspected acute myocardial infarction.
    Haaf P, Balmelli C, Reichlin T, Twerenbold R, Reiter M, Meissner J, Schaub N, Stelzig C, Freese M, Paniz P, Meune C, Drexler B, Freidank H, Winkler K, Hochholzer W, Mueller C.
    Am J Med; 2011 Aug 15; 124(8):731-9. PubMed ID: 21787902
    [Abstract] [Full Text] [Related]

  • 18. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

  • 19. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C, Raymond I, Pedersen F, Gustafsson F, Faber J, Hildebrandt P.
    JAMA; 2005 Apr 06; 293(13):1609-16. PubMed ID: 15811980
    [Abstract] [Full Text] [Related]

  • 20. Role of renal function and cardiac biomarkers (NT-proBNP and Troponin) in determining mortality and cardiac outcome in atheromatous renovascular disease.
    Chrysochou C, Manzoor S, Wright J, Roberts SA, Wood G, McDowell G, Kalra PA.
    Kidney Blood Press Res; 2009 Apr 06; 32(5):373-9. PubMed ID: 19887825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.